OpenVSafe by OpenVAERS
Search V-safe

U3J-29919-31010

1 vaccination 2 coded responses 15 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
064 / CT
Registered
2022-07-28
Relationship
Child or adolescent in my care
Guardian
WHG-73641-98334
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-28
    Registered in v-safe
  2. 2022-07-28
    Dose 1 — Moderna
  3. 2022-07-28
    Health check-in — day 0, dose 1, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  4. 2022-07-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-30
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-07-31
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-08-01
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  8. 2022-08-02
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-08-03
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-08-04
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-08-11
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-08-18
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-08-25
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-09-01
    Health check-in — day 35, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-09-11
    Survey response — day 42, dose 1, under 3
    MedDRA: Irritability, Pyrexia, Rash — Feeling: Good · Be unable to do your normal daily activities
    Free text: Fever, rash, irritability x 5 days
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-10-27
    Survey response — 3 months, dose 1, under 3
    MedDRA: Cough, Eye discharge, Nasal congestion, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: Fever, runny/stuffy nose, cough, eye discharge
    MedDRA releases: 2024-11 · check-in free text available
  17. 2023-01-26
    Health check-in — 6 months, dose 1, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-07-28Moderna No

Free text

Release 12 (Under 3) — day 42, dose 1, under 3

2022-09-11

Symptoms: Fever, rash, irritability x 5 days

Release 12 (Under 3) — 3 months, dose 1, under 3

2022-10-27

Symptoms: Fever, runny/stuffy nose, cough, eye discharge

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDEye discharge · · ✓
SDIrritability · · ✓
SDNasal congestion · · ✓
SDPyrexia · · ✓
SDRash · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release